The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis
18-month efficacy and safety update from JAVELIN Merkel 200 part A: A phase II study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy.
 
Sandra P. D'Angelo
Consulting or Advisory Role - Amgen; EMD Serono; Nektar
 
Jeffery Scott Russell
Employment - Immunocore
Consulting or Advisory Role - EMD Serono
 
Shailender Bhatia
Stock and Other Ownership Interests - Halozyme
Honoraria - Genentech; Novartis; Prometheus
Consulting or Advisory Role - Genentech
Speakers' Bureau - Novartis; Prometheus
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); Immune Design (Inst); Merck (Inst); Novartis (Inst); OncoSec (Inst)
 
Omid Hamid
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Novartis; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Genentech; Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Genentech (Inst); Immunocore (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Rinat (Inst); Roche (Inst)
 
Janice M. Mehnert
Honoraria - EMD Serono; Genentech
Consulting or Advisory Role - Amgen; Merck Sharp & Dohme
Research Funding - Amgen (Inst); AstraZeneca (Inst); Immunocore (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - EMD Serono; Merck Sharp & Dohme
Other Relationship - Amgen; EMD Serono; Merck; Merck
 
Patrick Terheyden
Honoraria - Bristol-Myers Squibb; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Kent C. Shih
No Relationships to Disclose
 
Isaac Brownell
No Relationships to Disclose
 
Celeste Lebbé
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Novartis; Roche
Research Funding - Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Karl D. Lewis
Research Funding - EMD Serono (Inst)
 
Gerald P. Linette
No Relationships to Disclose
 
Michele Milella
No Relationships to Disclose
 
Meliessa Hennessy
Employment - EMD Serono
 
Marcis Bajars
Employment - EMD Serono
 
Isabella Zwiener
Employment - Merck KGaA
 
Paul Nghiem
Honoraria - EMD Serono; Merck Sharp & Dohme
Consulting or Advisory Role - EMD Serono; Pfizer
Research Funding - Bristol-Myers Squibb; EMD Serono
Travel, Accommodations, Expenses - EMD Serono